Group One Trading’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Other funds holding LENZ
7IH
Group One Trading's LENZ Position: Q3 2026 in Review
Group One Trading reduced its LENZ Therapeutics (LENZ) stake by 36% in Q3 2026, selling an estimated $7.6K and leaving 2,765 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6278.
Group One Trading first reported a position in LENZ in Q4 2023 and has held it in 6 quarters since. The position peaked at $41.3K in Q1 2026. 138 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.
- Group One Trading held 2,765 shares of LENZ Therapeutics worth $10.6K as of Q3 2026.
- Group One Trading sold 1,527 LENZ Therapeutics shares in Q3 2026, an estimated $7.6K.
- LENZ Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #6278 holding.
- Group One Trading first reported a position in LENZ Therapeutics in Q4 2023 and has held it in 6 quarters since.
- Group One Trading's LENZ Therapeutics position peaked at $41.3K in Q1 2026.
- 138 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.